Search research articles
Contact Us
Filters
Showing results (71-80 of 1,058) with videos related to
Page
of 106
Sort By:
Blood
|
July 28, 2021
Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies
Deborah M Stephens, John C Byrd
Leukemia & Lymphoma
|
March 16, 2013
Emerging drug profile: cyclin-dependent kinase inhibitors
James S Blachly, John C Byrd
Oncology (Williston Park, N.Y.)
|
January 22, 2013
Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approaches
Deborah M Stephens, John C Byrd
Hematology/Oncology Clinics of North America
|
April 9, 2013
Improving the treatment outcome of patients with chronic lymphocytic leukemia through targeted antibody therapy
Deborah M Stephens, John C Byrd
The Journal of the American Osteopathic Association
|
February 1, 1987
Schamberg's disease: report of a case
S A Friedman, R C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2007
Have we forgotten the purpose of phase III studies?
Joseph M Flynn, John C Byrd
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
New strategies in chronic lymphocytic leukemia: shifting treatment paradigms
Farrukh T Awan, John C Byrd
Nature Reviews. Clinical Oncology
|
May 20, 2021
Whole-genome sequencing for myeloid disease: one assay to stratify them all?
Karilyn T M Larkin, John C Byrd
Journal of Molecular Graphics & Modelling
|
October 17, 2015
Development of quantitative structure property relationships for predicting the melting point of energetic materials
Jason A Morrill, Edward F C Byrd
The Journal of Physical Chemistry. A
|
January 20, 2006
Improved prediction of heats of formation of energetic materials using quantum mechanical calculations
Edward F C Byrd, Betsy M Rice
Page
of 106
Search research articles
Search
Showing results (71-80 of 1,058) with videos related to
Sort By:
Page
of 106
Blood
|
July 28, 2021
Resistance to Bruton tyrosine kinase inhibitors: the Achilles heel of their success story in lymphoid malignancies
Deborah M Stephens, John C Byrd
Leukemia & Lymphoma
|
March 16, 2013
Emerging drug profile: cyclin-dependent kinase inhibitors
James S Blachly, John C Byrd
Oncology (Williston Park, N.Y.)
|
January 22, 2013
Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approaches
Deborah M Stephens, John C Byrd
Hematology/Oncology Clinics of North America
|
April 9, 2013
Improving the treatment outcome of patients with chronic lymphocytic leukemia through targeted antibody therapy
Deborah M Stephens, John C Byrd
The Journal of the American Osteopathic Association
|
February 1, 1987
Schamberg's disease: report of a case
S A Friedman, R C Byrd
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2007
Have we forgotten the purpose of phase III studies?
Joseph M Flynn, John C Byrd
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2014
New strategies in chronic lymphocytic leukemia: shifting treatment paradigms
Farrukh T Awan, John C Byrd
Nature Reviews. Clinical Oncology
|
May 20, 2021
Whole-genome sequencing for myeloid disease: one assay to stratify them all?
Karilyn T M Larkin, John C Byrd
Journal of Molecular Graphics & Modelling
|
October 17, 2015
Development of quantitative structure property relationships for predicting the melting point of energetic materials
Jason A Morrill, Edward F C Byrd
The Journal of Physical Chemistry. A
|
January 20, 2006
Improved prediction of heats of formation of energetic materials using quantum mechanical calculations
Edward F C Byrd, Betsy M Rice
Page
of 106